SIDA 2006 y más allá.

Same author

Penile human papilloma virus (HPV) in high risk populations with and without HIV: Epidemiological insights from Argentina.

International journal of STD & AIDS·2026

Same author

Switch to single-tablet bictegravir-lenacapavir from a complex HIV regimen (ARTISTRY-1): a randomised, open-label, phase 3 clinical trial.

Lancet (London, England)·2026

Same author

Efficacy and safety of a mosaic HIV-1 vaccine regimen in men who have sex with men and transgender individuals (HVTN 706/HPX3002/Mosaico): a global, randomised, double-blind, placebo-controlled, phase 3 trial.

The lancet. HIV·2025

Same author

Integrative functional genomics analysis of Kaposi sarcoma cohorts.

Scientific reports·2025

Same author

VH3810109 Efficacy, Safety, Pharmacokinetics, and Incidence of Antidrug Antibodies in Adults With HIV-1 Naive to Antiretroviral Therapy: BANNER Study Results.

The Journal of infectious diseases·2025

Same author

Efficacy and Safety of Dual Therapy With Dolutegravir/Lamivudine in Treatment-naive Persons With CD4 Counts <200/mm3: 48-Week Results of the DOLCE Study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025

Videos de Experimentos Relacionados

SIDA 2006 y más allá.

Videos de Conceptos Relacionados

Penile human papilloma virus (HPV) in high risk populations with and without HIV: Epidemiological insights from Argentina.

Switch to single-tablet bictegravir-lenacapavir from a complex HIV regimen (ARTISTRY-1): a randomised, open-label, phase 3 clinical trial.

Efficacy and safety of a mosaic HIV-1 vaccine regimen in men who have sex with men and transgender individuals (HVTN 706/HPX3002/Mosaico): a global, randomised, double-blind, placebo-controlled, phase 3 trial.

Integrative functional genomics analysis of Kaposi sarcoma cohorts.

VH3810109 Efficacy, Safety, Pharmacokinetics, and Incidence of Antidrug Antibodies in Adults With HIV-1 Naive to Antiretroviral Therapy: BANNER Study Results.

Efficacy and Safety of Dual Therapy With Dolutegravir/Lamivudine in Treatment-naive Persons With CD4 Counts <200/mm3: 48-Week Results of the DOLCE Study.

Videos de Experimentos Relacionados

SIDA 2006 y más allá.

Videos de Conceptos Relacionados

Penile human papilloma virus (HPV) in high risk populations with and without HIV: Epidemiological insights from Argentina.

Switch to single-tablet bictegravir-lenacapavir from a complex HIV regimen (ARTISTRY-1): a randomised, open-label, phase 3 clinical trial.

Efficacy and safety of a mosaic HIV-1 vaccine regimen in men who have sex with men and transgender individuals (HVTN 706/HPX3002/Mosaico): a global, randomised, double-blind, placebo-controlled, phase 3 trial.

Integrative functional genomics analysis of Kaposi sarcoma cohorts.

VH3810109 Efficacy, Safety, Pharmacokinetics, and Incidence of Antidrug Antibodies in Adults With HIV-1 Naive to Antiretroviral Therapy: BANNER Study Results.

Efficacy and Safety of Dual Therapy With Dolutegravir/Lamivudine in Treatment-naive Persons With CD4 Counts <200/mm3: 48-Week Results of the DOLCE Study.

Videos de Experimentos Relacionados

SIDA 2006 y más allá.

Videos de Conceptos Relacionados

Artículos Relacionados

Penile human papilloma virus (HPV) in high risk populations with and without HIV: Epidemiological insights from Argentina.

Switch to single-tablet bictegravir-lenacapavir from a complex HIV regimen (ARTISTRY-1): a randomised, open-label, phase 3 clinical trial.

Efficacy and safety of a mosaic HIV-1 vaccine regimen in men who have sex with men and transgender individuals (HVTN 706/HPX3002/Mosaico): a global, randomised, double-blind, placebo-controlled, phase 3 trial.

Integrative functional genomics analysis of Kaposi sarcoma cohorts.

VH3810109 Efficacy, Safety, Pharmacokinetics, and Incidence of Antidrug Antibodies in Adults With HIV-1 Naive to Antiretroviral Therapy: BANNER Study Results.

Efficacy and Safety of Dual Therapy With Dolutegravir/Lamivudine in Treatment-naive Persons With CD4 Counts <200/mm3: 48-Week Results of the DOLCE Study.

Videos de Experimentos Relacionados

SIDA 2006 y más allá.

Videos de Conceptos Relacionados

Artículos Relacionados

Penile human papilloma virus (HPV) in high risk populations with and without HIV: Epidemiological insights from Argentina.

Switch to single-tablet bictegravir-lenacapavir from a complex HIV regimen (ARTISTRY-1): a randomised, open-label, phase 3 clinical trial.

Efficacy and safety of a mosaic HIV-1 vaccine regimen in men who have sex with men and transgender individuals (HVTN 706/HPX3002/Mosaico): a global, randomised, double-blind, placebo-controlled, phase 3 trial.

Integrative functional genomics analysis of Kaposi sarcoma cohorts.

VH3810109 Efficacy, Safety, Pharmacokinetics, and Incidence of Antidrug Antibodies in Adults With HIV-1 Naive to Antiretroviral Therapy: BANNER Study Results.

Efficacy and Safety of Dual Therapy With Dolutegravir/Lamivudine in Treatment-naive Persons With CD4 Counts <200/mm3: 48-Week Results of the DOLCE Study.